Cogent Biosciences, Inc.
NASDAQCogent Biosciences heads into its August 13 earnings report with options traders at their most bullish in a year and a meaningful short position that has started to retreat — a setup that makes the print feel secondary to the November FDA decision looming over everything. The options signal is the sharpest data point this week. Call positioning has surged to an extreme, with the…
Snapshot as of 8 Aug 2026
Cogent Biosciences heads into its August 13 earnings report with options traders at their most bullish in a year and a meaningful short position that has started to retreat — a setup that makes the print feel secondary…
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for COGT — free to start on ORTEX.
Sign up for free →Open COGT on ORTEX